← Back

Outreach News

Wednesday, 24 August 2016

Prof Laura M. Lechuga describes the ideal point-of-care device for The Pathologist

In a dissemination article the leader of the ICN2 Nanobiosensors and Bioanalytical Applications Group offers her view about the future of point-of-care diagnostics.  

The Pathologist recently published an article by Prof Laura M. Lechuga, Group leader of the the ICN2 Nanobiosensors and Bioanalytical Applications Group, where she shares her opinion about how mobile devices promise a new future of point-of-care diagnostics for all.

In the article linked below she states: “In my view, the ideal POC device should be disposable, require no external power source, be able to deliver the result in less than five minutes, allow for the analysis of several biomarkers in the same fluid sample, and should cost less than US$1”. Uau!